Proscillaridin
Jump to navigation
Jump to search
Clinical data | |
---|---|
Other names | 14β-Hydroxy-3β-[α-L-rhamnopyranosyl)oxy]bufa-4,20,22-trienolide |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.702 |
Chemical and physical data | |
Formula | C30H42O8 |
Molar mass | 530.658 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Proscillaridin is a cardiac glycoside, a kind of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia (irregular heartbeat). It is of the bufanolide type and can be obtained from plants of the genus Scilla and in Drimia maritima (Scilla maritima).[1]
The aglycone of proscillaridin is scillarenin.
References
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles with changed CASNo identifier
- ECHA InfoCard ID from Wikidata
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Rhamnosides
- Bufanolides
- All stub articles
- Cardiovascular system drug stubs